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Association	 of	 Clinical	 Microbiologists	 updated	 the	 recommendations	 for	 the	 di-































biology-based	 syndromic	 panels)	 have	 revolutionized	 the	 work-
flow	of	clinical	microbiology	laboratories	(Brooks,	2013;	Laupland	
&	Valiquette,	 2013;	Opota,	 Corxatto,	 &	 Prod’hom	G.,	 Greub	G.,	










flow	 for	bloodstream	 infections	 (BSIs),	 based	on	 the	most	 recent	
evidences	(GLIPaC,	2014).	The	objectives	of	the	revision	included	
(a)	reviewing	the	workflow	in	consideration	of	recent	technological	
advances,	 (b)	providing	standard	operating	procedures	 (SOPs)	 for	








2  | MATERIAL S AND METHODS
2.1 | Participants and data collection
A	 total	 of	 168	 microbiologists	 (from	 168	 laboratories)	 were	 in-







specialists.	 All	 interviewed	were	 bioMérieux	 customers	who	 used	
the	BACT/ALERT	3D	BC	monitoring	system	(bioMérieux).	The	ques-
tionnaires	were	collected	and	processed	anonymously.
Each	 question	 had	 four	 possible	 answers.	 For	 each	 choice,	 a	










	 5.	 Are	 repeated	 withdrawals	 performed	 for	 the	 same	 patient	 in	
days	following	the	first?
	 6.	 What	 is	 the	 percentage	 of	 single	 blood	 cultures	 collected	 (in	
adult	patients)?






























Results	 were	 merged	 to	 calculate	 an	 average	 questionnaire	
score	per	 center	 and	 an	 average	 answer	 score,	 for	 each	question,	
intercenter.
3  | RESULTS
Overall,	 168	 microbiologists	 from	 168	 laboratories	 were	 inter-
viewed.	The	laboratories	served	a	total	of	204	acute	care	hospitals	
and	 postacute	 care	 facilities.	 The	 geographic	 distribution	 of	 the	
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laboratories	was	as	follows:	68	in	northern	Italy,	59	in	central	Italy,	
and	41	in	southern	Italy.
Figure	 1	 shows	 the	 average	 answer	 score	 for	 each	 question.	
Question	no.	16	was	excluded	from	the	evaluation	because	of	the	
low	number	of	responses.	Questions	no.	7,	11,	13,	and	19	yielded	
the	 lowest	 average	 scores.	 Among	 these,	 question	 no.	 7	 (no.	 of	
sets	of	blood	cultures	carried	out	for	1,000	days	of	hospitalization)	
yielded	 the	 lowest	 score.	 Only	 the	 58%	 of	 laboratories	 (98/168)	
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were	able	to	monitor	this	parameter,	and	only	in	11%	(19/168),	the	
parameter	was	 in	 the	expected	range	 (Table	1).	Answers	to	ques-










Dargère,	Arendrup,	 Parienti,	 &	 Tattevin,	 2016).	 Concerning	 ques-
tion	 no.	 19,	 89%	 of	 laboratories	 involved	 (150/168)	were	 able	 to	
report	data	on	contamination	rate;	only	12%	(18/150)	were	in	the	
expected	 range	 (2%–3%),	while	 a	 significant	 number	 of	 hospitals	
were	largely	beyond	scale	(Table	1).
Questions	no.	1,	3,	8,	9,	12,	and	14	were	those	which	yielded	an	
average	 answer	 score	 ≥2,	 indicating	 satisfactory	 adherence	 of	 the	
laboratories	to	the	recommendations	 (Figure	1).	 In	particular,	ques-
tion	no.	1	assessed	compliance	with	the	best	practice	statement	that	




































As	Miller	 et	 al.	 stated	 in	 their	 guidelines,	 "the	diagnosis	 of	 blood-
stream	 infections	 is	 one	 of	 the	 most	 critical	 functions	 of	 clinical	
microbiology	 laboratories"	 (Miller	 et	 al.,	 2018).	 Therefore,	 it	 is	 of	
fundamental	 importance	 for	 microbiologists,	 based	 on	 the	 avail-
able	 technological	 and	 human	 resources,	 to	 implement	 a	 diagnos-
tic	workflow	capable	of	returning	useful	results	to	clinicians	in	the	
shortest	possible	timeframe	to	maximize	impact	on	clinical	decisions	
and	 patients	 outcomes	 (Serpa-Pinto	 &	 Cardoso,	 2014;	 Seymour	
et	al.,	2017;	Yealy	et	al.,	2015).	Monitoring	 suitable	 indicators	can	
contribute	 to	 these	purposes	 (Lamy,	 Ferroni,	Henning,	Cattoen,	&	
Laudat,	2018).	Therefore,	 the	 rules	 and	 indicators	 reported	 in	our	
recommendations	should	not	be	perceived	as	a	burden	for	the	labo-
ratory	but	 rather	as	a	guidance	 to	 improve	 the	use	of	BCs	 for	 the	
benefit	of	patients	(GLIPaC,	2014).
F I G U R E  2  Number	of	set	received	for	each	BC,	expressed	in	
percentage	for	each	Hospital.	A	(1)	=	one	set;	B	(2)	=	two	sets;	C	
(3)	=	three	sets;	D	(4)	=	four	sets









to	 the	 recommendations	 is	 still	 far	 from	satisfactory.	Some	of	 these	
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TA B L E  A 1   (Continued)
(Continues)
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